Skip to main content
BeOne Medicines Ltd. (SHA:688235)
China flag China · Delayed Price · Currency is CNY
230.20
+2.10 (0.92%)
May 30, 2025, 3:00 PM CST

BeOne Medicines Revenue

BeOne Medicines had revenue of 8.05B CNY in the quarter ending March 31, 2025, with 48.28% growth. This brings the company's revenue in the last twelve months to 30.34B, up 52.09% year-over-year. In the year 2024, BeOne Medicines had annual revenue of 27.81B with 59.51% growth.

Revenue (ttm)
30.34B
Revenue Growth
+52.09%
P/S Ratio
6.91
Revenue / Employee
2.76M
Employees
11,000
Market Cap
209.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202427.81B10.38B59.51%
Dec 31, 202317.43B7.67B78.53%
Dec 31, 20229.77B2.29B30.69%
Dec 31, 20217.47B5.46B270.56%
Dec 31, 20202.02B-965.08M-32.37%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jiangsu Hengrui Medicine 29.19B
Shenzhen Mindray Bio-Medical Electronics 35.59B
WuXi AppTec 39.59B
Zhangzhou Pientzehuang Pharmaceutical., 10.76B
Aier Eye Hospital Group 21.81B
Shanghai United Imaging Healthcare 10.43B
Sichuan Biokin Pharmaceutical 5.82B
Yunnan Baiyao Group Co.,Ltd 40.10B
Revenue Rankings

BeOne Medicines News

More News